JENNIFER WARGO to Fluorescent Antibody Technique
This is a "connection" page, showing publications JENNIFER WARGO has written about Fluorescent Antibody Technique.
Connection Strength
0.052
-
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer. Nat Med. 2017 May; 23(5):551-555.
Score: 0.030
-
BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma. Clin Cancer Res. 2013 Mar 01; 19(5):1225-31.
Score: 0.022